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ABSTRACT 
Ion-pairing is reported to improve the lipophilicity and subsequently the transport rate of polar drugs across 
lipid membranes. Lipophilisation of ionic drugs with high aqueous solubilities by ion-pair formation with 
appropriate counter-ion have proven to be promising for several applications. The aim of this review is to 
present the usefulness of ion-pair for improving the poor bioavailability of ionic drugs through various routes. 
The review covers an update on the applications of this strategy to improve drug delivery through various 
routes of administration including ocular, oral, parenteral and transdermal. It is discussed how ion-pair 
complexes assist in introducing functionality that would allow formation of a neutral molecule which can be 
subsequently encapsulated into delivery systems to be distributed by various routes of administration. 
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INTRODUCTION 
Ion-pair is a pair of oppositely charged ions held 
together by Coulomb attraction without formation 
of a covalent bond. They behave like a single unit. 
Hydrophobic ion pairing technique has been used 
to increase the hydrophobicity of molecules 
containing ionizable groups by stoichiometric 
replacement of the polar counter ions with more 
hydrophobic ones (Choi and Park, 2000). Ion-
paired delivery has emerged as a viable approach 
for enhancing solubility of ionic molecules in non-
polar solvents, augmentation of protein and DNA 
transport and addressing the poor bioavailability 
issues of hydrophilic drugs (Neubert, 1989; 
Neubert and Dittrich, 1990; Van et al., 1999; Kamal 
et al., 2007; Chorny et al., 2007; Rastogi et al., 2009; 
Ma et al., 2010; Hao et al., 2010). In this review, the 
application of ion paired system to delivery of drugs 




Charged drug molecules do not readily partition 
into or permeate through human skin. Formation of 
lipophilic ion-pairs can increase stratum corneum 
penetration of charged species. This strategy 
involves adding an oppositely charged species to 
the charged drug, forming an ion-pair in which the 
charges are neutralised so that the complex can 
partition into and permeate through the stratum 
corneum. The ion-pair then dissociates in the 
aqueous microenvironment of the epidermis 
releasing the parent charged drug which can diffuse 
within the epidermal and dermal tissues (Megwa et 
al., 2000; Valenta et al., 2000).  
 
Sarveiya et al. (2004) reported a 16-fold increase in 
the steady-state flux of ibuprofen ion-pairs across a 
lipophilic membrane. They determined the 
influence of pH and ion-pairing on the permeation 
of ibuprofen across polydimethylsiloxane (PDMS) 
membrane. Diffusion studies at different pH values 
(4.0, 5.0, 6.0, 7.0 and 8.0) indicated that ibuprofen 
sodium flux increased significantly with increasing 
pH from 4.0 to 7.0. Above pH 7.0, a decrease in 
diffusion was observed. The permeability 
coefficient increased with an increase in the 
amount of unionized acid. 
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Some workers studied the possibility of improving 
the efficiency of transdermal delivery of salicylate 
through human epidermis by ion-pair formers 
(alkylamines and quaternary ammonium ions). The 
relationship between the physicochemical 
properties of the counter-ions and salicylate flux 
was examined. It was found that flux can be 
correlated to the conductivity associated with the 
penetrant solution, molecular size of the counter-
ion and lipophilicity expressed as either 
octanol/water partition coefficient of the ion pairs 
or the carbon chain-length of the counter-ions. 
Mathematical models have been developed to 
predict salicylate flux from these physicochemical 
parameters (Megwa et al., 2000). 
 
Nash et al. (1992) tested the ion pair absorption 
hypothesis with respect to the topical route of drug 
delivery. The experiment consisted of preparing 
various lidocaine-n-alkanoate ion pairs, then 
characterizing them by proton magnetic resonance 
spectroscopy, elemental analysis and conductivity. 
Percutaneous absorption studies through excised 
hairless mouse skin were carried out using 
ethanolic solution of radiolabeled 14C-lidocaine-
octanoate, 14C-lidocaine-decanoate and 14C-
lidocaine-dodecanoate. The difference between the 
flux values of lidocaine-1-14C-dodecanoate and 14C-
lidocaine-dodecanoate infers that lidocaine-
dodecanoate did not cross the excised, full-
thickness, hairless mouse skin as an intact 1:1 ion 
pair.  
To improve transdermal delivery of meloxicam, 
Zhang et al. (2009) studied ion-pair formation with 
six organic bases, diethylamine, triethylamine, 
ethanolamine, diethanolamine, triethanolamine, 
and N-(2'-hydroxyethanol)-piperidine. The authors 
proved the formation of a meloxicam/amine ion-
pair in solution by (13) C-NMR (nuclear magnetic 
resonance). Their results suggested that the degree 
of enhancement possibly depends on the structure 
and hydrophilicity of the counter ions. The 
enhancing effect of ion-pairing on the skin 
permeation of Glipizide was studied by Tan et al. 
(2009). (13)C NMR spectroscopy was used to 
identify the ion-pairing formation between 
Glipizide and the respective counter-ion and the 
effect of an interaction with amines as counter-ions, 
including diethylamine, triethylamine, 
ethanolamine, diethanolamine, triethanolamine, N-
(2-hydroxylethyl) piperidine with Glipizide was 
observed. All the amines investigated in the study 
exhibited enhancing effect on Glipizide flux, and 
triethylamine had the most potent enhancing effect. 
The study concluded that the formation of ion-pairs 
between Glipizide and counter ions is a useful 
method to promote the skin permeation of 
Glipizide. 
Ocular Delivery 
In 2000, Sznitowska and other workers prepared 
submicron emulsions containing pilocarpine as ion-
pair with mono-dodecylphosphoric acid 
(Sznitowska et al., 2000). Physical stability of these 
preparations was confirmed during 4 months of 
storage at 4oC. Approximately 50% of the drug was 
found in the aqueous phase of emulsion separated 
using an ultrafiltration technique, while the rest 
was present in the oily phase and interphase. The 
miotic effect observed in rabbits after application of 
the ion-pair in aqueous solution or in submicron 
emulsion was the same; indicating that the drug 
distribution into the oily phase of the colloidal 
vehicle does not improve ocular bioavailability.  
An exhaustive study carried out by Trotta et al. 
(2002) assessed the ion pairing of retinoic acid 
(R.A) using microemulsions as delivery vehicles to 
influence the topical permeation. Phenylalanine 
methyl ester, phenylalanine ethyl ester, histidine 
methyl ester, tryptophan methyl ester and valine 
methyl ester were used as counter ions. The results 
recommended that O/W microemulsions 
containing a counter-ion can be used to optimise 
drug targeting without a concomitant increase in 
systemic absorption. Aqueous dispersions of solid 
lipospheres containing up to 7.5% pilocarpine as 
lipophilic ion pairs were prepared by Cavalli et al. 
(1995). The lipospheres had a size range between 
75-85 nm, consisted mainly of stearic acid and egg 
lecithin; pilocarpine base was incorporated as ion 
pair with mono-octylphosphate, mono-
decylphosphate and mono-hexade-cylphosphate. 
The authors concluded a promising result for 
sustained ocular delivery of pilocarpine. 
Oral Delivery 
Antiviral drugs often suffer from poor intestinal 
permeability, preventing their delivery via the oral 
route. Miller et al. (2010) utilised an ion-pairing 
approach of the low-permeability antiviral agents 
zanamivir heptyl ester (ZHE) and guanidino 
oseltamivir (GO). The counterion 1-hydroxy-2-
naphthoic acid (HNAP) was utilised to enhance the 
lipophilicity and permeability of the highly polar 
drugs. 
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HNAP enhanced the apparent permeability of both 
compounds across Caco-2 cell monolayers in a 
concentration-dependent manner. Consistent with 
a quasi-equilibrium transport model, a linear 
relationship with slope near 1 was obtained from a 
log-log plot of Caco-2 P (app) versus HNAP 
concentration, supporting the ion-pair mechanism 
behind the permeability enhancement. 
 
The potential of ion-pair formation to improve the 
oral absorption was studied by Gelder et al. (1999) 
for two highly potent and selective antiretroviral 
agents viz., 9-(2-phosphonyomethoxypropyl) 
adenine (PMPA) and AMD3100. Transepithelial 
transport of these two agents is very poor as PMPA 
is negatively charged and AMD3100 is positively 
charged at physiological pH. Ion pair formation was 
carried out to solve this problem. Positively charged 
counter ions such as t-hexyl-, t-heptyl-, t-
octylammonium bromide and dodecyl-, tetradecyl-, 
hexadecyltrimethylammonium bromide were used 
to form ion pairs with PMPA, while sodium 
taurodeoxycholate (in vitro experiments) and 
sodium taurocholate (in vivo experiments) were 
used as counter ions for AMD3100.  
 
Results obtained from partitioning studies of the 
drugs in the presence or absence of counter ion 
revealed that competition by other ions was 
responsible for the absence of an effect: when pure 
water was used as the aqueous phase, a reduction 
of the initial aqueous concentration was observed 
for both the agents; however, as soon as other ions 
were present in the aqueous phase, the effect of the 
counter ion was diminished or completely 
abolished. The oral bioavailability in rabbits 
revealed that, AMD3100 in the presence of 4 
equivalents of taurocholic acid remained very low 
and was only 3.2-fold better (i.e. 3.6%) in 
comparison to pure AMD3100. The authors 
concluded that the formation of ion pairs may not 
be very efficient as a strategy to enhance 
transepithelial transport of charged hydrophilic 
compounds, as competition by other ions may 
abolish the beneficial effect of counter ions. 
 
Parenteral Route 
A study compared the pharmacokinetics of 
doxorubicin incorporated as ion-pair into solid lipid 
nanospheres (SLN) with that of the commercial 
solution of the drug. Male albino rats (Wistar-
derived strain) were treated i.v. with equivalent 
doses (6mg kg-1) of two different doxorubicin 
formulations: an aqueous dispersion of SLN 
carrying doxorubicin and a commercial doxorubicin 
solution (Adriablastina). These formulations were 
injected, under general anaesthesia, through a 
cannula into the jugular vein and blood samples 
were collected at 1, 15, 30, 45, 60, 120 and 180 min 
after administration. After 180 min rats were killed 
and samples of liver, heart, lung, kidney, spleen and 
brain were collected. Blood and tissue samples 
were analysed by a spectrofluorimetric method. 
The anthracycline concentration in the blood was 
markedly higher at each point times with the SLN 
than with the commercial solution. The drug 
concentration was also higher in the lung, spleen 
and brain. SLN-treated rats showed a lower 
doxorubicin concentration in liver, heart and 
kidney. The results showed that SLN increased the 
area under the curve (0-180 min) of doxorubicin 
compared to conventional doxorubicin solution and 
led to a different body distribution profile (Zara et 
al., 1999). The doxorubicin present as ion-pair 
complex has enhanced lipophilicity which resulted 
in an increment in apparent partition coefficient 
between lipid and water enabling higher drug 
payloads and bio-distribution. 
 
Miscellaneous  
Ion-pair drug delivery can also apply for inhalation 
therapy for infectious lung diseases like 
tuberculosis. Potent anti-tuberculosis drug, 
isoniazid was modified into an ionizable form 
suitable for hydrophobic ion pairing. The charged 
prodrug, sodium isoniazid methanesulfonate (Na-
INHMS), was then ion paired with hydrophobic 
cations, such as alkyl-trimethylammonium or tetra-
alkylammonium. The water solubility of the tetra-
heptylammonium-INHMS complex is about 220-
fold lower than that of Na-INHMS. The half-life of 
this HIP complex is on the order of 30 min, making 
the enhanced transport of the drug across biological 
barriers possible. This work represents use of a 
pro-drug approach to introduce functionality that 
would allow hydrophobic ion pairing complex 
formation for a neutral molecule (Zhou et al., 2002). 
Zimmer fabricated polyalkylcyanoacrylate 
nanoparticles by an emulsion polymerization 
process and antisense oligonucleotides were loaded 
on the particles by adsorption. A cationic polymer, 
DEAE-dextran, was incorporated into the particle 
matrix or a cationic hydrophobic detergent (CTAB) 
was used to form a lipophilic oligonucleotide ion 
pair. Enzymatic digestion of the oligonucleotide was 
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almost quantitatively inhibited by this nanoparticle 
complex and cellular uptake by different cell lines 
was significantly enhanced. In vivo, the bio-
distribution of the oligonucleotide nanoparticle 
complex resulted in targeting of oligonucleotides to 
the liver. Improvements in antisense treatments 
with nanoparticles were demonstrated for tumor 
therapy as well as for antiviral applications 
(Zimmer, 1999). 
 
Sineerat et al. (2008) investigated a water insoluble 
complex of cationic propranolol HCl with anionic 
sodium lauryl sulfate. They concluded that the 
‘propranolol-sodium lauryl sulfate complex’ 
provided promising sustained drug delivery and 
were feasible to be encapsulated in microparticles 
for a more sustained drug release effect. Austin et 
al. (1998) studied the distribution of salmeterol and 
proxicromil between unilamellar vesicles of 
dioleoylphosphatidylcholine (DOPC) and aqueous 
buffer at pH 7.4, using an ultrafiltration method, as 
a function of compound concentration, DOPC 
concentration, and buffer ionic strength. The 
binding of these ionized lipophilic compounds to 
neutral DOPC vesicles induces a surface charge, 
which causes the observed membrane distribution 
coefficient D (mem)obs to vary significantly with 
bound compound to DOPC ratio and with ionic 
strength. This variability is shown to be well-
described with use of the Gouy-Chapman theory of 
the ionic double layer and is contrasted with the 
ideal behavior shown by the neutral compound 
clofibrate.  
 
Increasing ionic strength is also shown to increase 
the observed 1-octanol-buffer distribution 
coefficients D (o/w) obs of proxicromil but through 
a very different mechanism involving the extraction 
of ion pairs. This study highlights the experimental 
difficulty in determining concentration-
independent liposome distribution coefficients of 
ionized lipophilic compounds and describes when 
deviations will be significant and how observed 
values may be corrected for such effects. The 
general effect of ionic strength on membrane-buffer 
distribution and 1-octanol-buffer distribution was 
discussed with particular reference to the very 
different propensity for ion pair formation shown 
by the two systems, and the most suitable 
experimental conditions that should be used with 
each system. 
De Verdiere et al. (1997) reported that 
polyalkylcyanoacrylate (PACA) nanoparticles 
loaded with doxorubicin allowed multidrug 
resistance to be overcome in vitro. However, 
increased cytotoxicity is not always correlated with 
an increased level of intracellular drug. They 
observed that a direct interaction between 
nanoparticles and cells is a necessary requirement 
for overcoming resistance. In addition, the results 
showed that the degradation products of PACA 
(mainly polycyanoacrylic acid) in the presence of 
doxorubicin were able to increase both 
accumulation and cytotoxicity, thus suggesting the 
formation of a doxorubicin-polycyanoacrylic acid 
ion-pair. It was concluded that resistance was 
overcome as a result of both the adsorption of 
nanoparticles to the cell surface and increased 
doxorubicin diffusion by the accumulation of an ion 
pair at the plasma membrane. 
Matschiner and colleagues developed a formulation 
with optimized penetration of the ion-pair between 
erythromycin and octadecansulfonate (Matschiner 
et al., 1995). The lipophilicity erythromycin by ion 
pairing was improved and the determination of 
lipophilicity was based on partition coefficients and 
on the penetration of ERY into a modified 
multilayer membrane system. It was shown that the 
penetration of erythromycin into a lipophilic 
acceptor system was three times higher when ion 
pairing was used in comparison with the 
penetration of the erythromycin base alone. The 
optimized formulation was compared with 
formulations containing ethanol and with the 
commercial product Zineryt. It was concluded that 
the dosage of the antibiotic used can be markedly 
reduced by optimizing a vehicle for the ion pair. 
The chemical reaction of vidarabine (VIDA) with 
isohexyl cyanoacrylate nanoparticles in a pH-
dependent fashion occurs only in the presence of 
dioctylsulfosuccinate (DOSS). The formation of an 
ion pair with DOSS allows a better contact of VIDA 
with the monomer during the polymerization 
process taking place in micelles. On the basis of 
molecular weight profiles of the polymer, 
determined by gel permeation chromatography 
(GPC), Guise et al. (1990) proposed that VIDA 
induces the polymerization of cyanoacrylic 
monomers through a zwitterionic pathway. This 
mechanism allows the covalent linkage of the drug 
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with the polymer, which is consistent with NMR 
experiments. The study illustrated the need for 
physicochemical studies in the design of new 
colloidal drug delivery formulations. 
 
Leuprolide acetate, an analogue of luteinizing 
hormone-releasing hormone (LH-RH), was 
hydrophobically ion paired with a long chain fatty 
acid, sodium oleate, in an aqueous solution (Choi 
and Park, 2000). It was found that with increasing 
the stoichiometric molar amounts of sodium oleate 
to leuprolide approached up to 2.5-3, the solution 
became gradually turbid with increasing particle 
sizes, indicating leuprolide precipitation as a result 
of hydrophobic ion pairing. On the other hand, 
beyond that critical molar ratio range, the solution 
turned clear with much reduced particle size, 
indicative of micelle formation. The 
hydrophobically modified leuprolide-oleate 
complex was lyophilized and directly encapsulated 
within biodegradable poly (D, L-lactic-co-glycolic 
acid) (PLGA) microspheres via a single oil-in-water 
(O/W) emulsion method. Microsphere morphology, 
leuprolide release behavior, and polymer mass 
erosion profiles were examined in comparison to 
the PLGA microspheres prepared with free 
leuprolide. The results indicated that ion-pairing 
rendered the protein more hydrophobic, increased 
its solubility in organic solvents and thereby 
improved its loading. 
CONCLUSION 
Ion-pairing can be a valuable tool for enhancing 
solubility and stability in an organic solvent. The 
complexes formed can be formulated into 
particulates with higher drug loading. This 
technique has found unique opportunities in 
delivery of polyelectrolytes (e.g. peptide, proteins, 
polynucleotide) by using them as hydrophobic ion-
paired moieties for designing particulates and 
microemulsions that during formulation require 
direct solubilization in organic solvents. 
Additionally, this approach can also improve 
stability and permeability across biological 
membranes. Formation of ion pairs normally does 
not entail an alteration in the structure and function 
of drug. Thus, this approach can assist in designing 
better dosage forms for alternative routes of 
administration.   
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